2021
DOI: 10.1007/s00210-021-02055-9
|View full text |Cite
|
Sign up to set email alerts
|

Double benefit of metformin treatment: improved bladder function in cyclophosphamide-induced cystitis and enhanced cytotoxicity in cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…With regard 907 to metformin effect on the bladder contractility, there were only few meeting reports and there was insufficient studies on the mechanism of action of metformin on the urinary bladder of rats. [9,10,11]. Studied that differential effects of metformin in rats' urinary bladder and other different tissues.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…With regard 907 to metformin effect on the bladder contractility, there were only few meeting reports and there was insufficient studies on the mechanism of action of metformin on the urinary bladder of rats. [9,10,11]. Studied that differential effects of metformin in rats' urinary bladder and other different tissues.…”
Section: Discussionmentioning
confidence: 99%
“…When TNF-α was applied to these cells with metformin, it was shown that they improved diabetic bladder dysfunction with together. In a study on the effects of cyclophosphamide and metformin on bladder dysfunction, it was revealed that metformin partially inhibited cycloffamide-induced cystitis [10]. When cyclophosphamide and metformin were combined, increased cytotoxicity was observed.…”
Section: Discussionmentioning
confidence: 99%
“…Cyclophosphamide (CYP), an oxazaphosphorine alkylating agent, was first successfully prepared by Norbert Brock in 1985 [1]. CYP is a prodrug that is widely used in the treatment of various malignancies and autoimmune diseases [2,3]. After administration, CYP is metabolized to 4hydroxycyclophosphamide in hepatocytes, and then enters the target cell for conversion to alkylated phosphoramide mustard, interfering with DNA replication and causing cell death [2,4].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, the treatment of Mesna may cause adverse reactions, such as ST segment elevation and asthenia [13]. Therefore, a more effective and safer strategy is needed to prevent bladder toxicity following CYP management [3].…”
Section: Introductionmentioning
confidence: 99%
“…1,1-Dimethylbiguanide hydrochloride, metformin (MET), is an anti-diabetic drug generally used for treatment of type II diabetes, which has been regarded to exert the neuroprotective through the anti-inflammatory (11) and antioxidant (12) actions. Recent studies have shown that MET has a protective effect against cyclophosphamideinduced cystitis in mice (13). Bladder dysfunction is very common in diabetes mellitus (14) and obesity (15).…”
Section: Introductionmentioning
confidence: 99%